Ignite Creation Date:
2024-05-05 @ 11:52 PM
Last Modification Date:
2024-10-26 @ 10:41 AM
Study NCT ID:
NCT01436838
Status:
COMPLETED
Last Update Posted:
2016-09-05
First Post:
2011-09-19
Brief Title:
China Betaferon Adherence Coping and Nurse Support Study
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
Prospective Study of Betaferon in Adherence Coping and Nurse Support in Patients of Chinese Origin With Multiple Sclerosis
Status:
COMPLETED
Status Verified Date:
2016-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Non-adherence reduces treatment benefit and can bias the assessment of treatment efficacy thereby involving safety risks for the patient and influencing health cost-effectiveness This observational study will concentrate upon the role of MS nurses in influencing adherence This study will examine the influence of initial and subsequent periodic nurse interviews which aim to improve adherence to Betaferon treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| BF1110CN | OTHER | Company Internal | None |